Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase Id/IIa multiple-ascending-dose study of ZT002 injection monotherapy in Chinese adults with type 2 diabetes mellitus
CTR20234165Phase 2Completed
- Sponsor
- Quality Peptide
- Start
- Jan 2024
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of zovaglutide in type 2 diabetes mellitus (T2DM), sponsored by Quality Peptide. Started Jan 2024; status: completed.
02
Drugs
zovaglutide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20234165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20234165.